Woong Hee Lee1, Hang Ren1, Jianfeng Wu1, Ondrej Novak2, Richard B Brown2, Chuanwu Xi1, Mark E Meyerhoff1. 1. Department of Chemistry, Department of Environmental Health Sciences, University of Michigan , Ann Arbor, Michigan 48109-1055, United States. 2. Department of Electrical and Computer Engineering, University of Utah , Salt Lake City, Utah 84112, United States.
Abstract
Herein, we report a novel design and the antimicrobial efficacy of a flexible nitric oxide (NO) releasing patch for potential wound healing applications. The compact sized polydimethylsiloxane (PDMS) planar patch generates NO via electrochemical reduction of nitrite ions mediated by a copper(II)-ligand catalyst using a portable power system and an internal gold coated stainless steel mesh working electrode. Patches are fabricated via soft lithography and 3-D printing. The devices can continuously release NO over 4 days and exhibit potent bactericidal effects on both Escherichia coli and Staphylococcus aureus. The device may provide an effective, safe, and less costly alternative for treating chronic wounds.
Herein, we report a novel design and the antimicrobial efficacy of a flexible nitric oxide (NO) releasing patch for potential wound healing applications. The compact sized polydimethylsiloxane (PDMS) planar patch generates NO via electrochemical reduction of nitrite ions mediated by a copper(II)-ligand catalyst using a portable power system and an internal gold coated stainless steel mesh working electrode. Patches are fabricated via soft lithography and 3-D printing. The devices can continuously release NO over 4 days and exhibit potent bactericidal effects on both Escherichia coli and Staphylococcus aureus. The device may provide an effective, safe, and less costly alternative for treating chronic wounds.
Entities:
Keywords:
3D printing; antimicrobial patch; electrochemical devices; nitric oxide release; portable planar NO generation
The normal wound healing process
involves inflammatory, proliferative, and remodeling phases under
the regulation of immune cells. However, chronic wounds fail to progress
in the normal time frame, and therefore enter a phase of prolonged
pathologic conditions, including chronic infection. Although the treatment
for chronic wounds often employs topical antimicrobials as well as
systemic antibiotics, the high incidence of drug-resistant strains
of bacteria and reduced regional circulation limits the therapeutic
effect of these conventional approaches to treating chronic wounds.[1−3]In vivo, endogenous production of nitric oxide (NO) plays
a dual
role as both a key agent in signaling and as a cytotoxic antimicrobial
agent.[4−6] Indeed, NO serves as a regulatory molecule for numerous
processes in the immune, nervous and cardiovascular systems. Nitric
oxide stimulates pro-inflammatory cytokines, keratinocytes, and fibroblasts,
and controls angiogenesis, collagen deposition and re-epithelialization.
In addition, NO has been shown to be an important component of the
host response during infection at a wound site.[7,8] The
antimicrobial properties of NO include serving as a signaling molecule
capable of dispersing microbial biofilm[9] on surfaces (including medical devices such as catheters[10]) and possessing bactericidal activity against
most strains of bacteria,[11] both Gram-positive
and Gram-negative.[12] Lower than normal
levels of endogenous NO are also associated with impaired wound healing
which can lead to chronic wounds.[13] Accordingly,
the addition of exogenous topical NO has the potential to enhance
the wound healing process, serving as both an antimicrobial agent
and also exhibiting significant pro-angiogenic properties (i.e., promoting
formation of new blood vessels).[14−16]A variety of NO
donors have been studied to create NO-releasingpolymers/materials for potential use in wound healing applications.[17] Nitric oxidedonor molecules, such as diazeniumdiolates
and S-nitrosothiols, have been incorporated into
various polymers or covalently linked to polymeric chains to enable
continuous secretion of NO in the presence of heat, light or metal
ions.[18] These new polymeric materials have
been utilized to reduce thrombosis (clotting) on blood contacting
biomedical devices, and microbial biofilm/infection on intravascular
and urinary catheters.[19,20] However, the limited NO reservoir
from NO donors and their instability at elevated temperatures or upon
exposure to moisture or light during storage results in a high cost
for any commercial product based on existing technology in this area.Recently, Ren et al. developed an electrochemically modulated NO
releasing catheter and successfully demonstrated that a significant
reduction in the bacterial biofilm formation occurs on the surface
in a drip-flow bioreactor inoculated with E. coli.[10] Within the lumen of the catheter,
a copper(II)-tri(2-pyridylmethyl)amine (CuTPMA) complex was used as
a mediator for the electrochemical reduction of nitrite to produce
NO at modest cathodic voltages (e.g., −0.3 to −0.5 V
vs Ag/AgCl). The NO produced within the catheter lumen is capable
of diffusing through the wall of the catheter to produce fluxes of
NO that rival those found physiologically from the surfaces of endothelial
and other cells in our bodies.In this work, we describe the
adaptation of this electrochemical
NO release chemistry to create a new type of NO emitting device that
could be employed as a wound-healing patch. A polydimethylsiloxane
(PDMS) housing is fabricated using a 3D printing soft lithography
method, allowing facile design of different configurations of patches.
PDMS was chosen to add more flexibility to the device so that it can
be readily applied onto the surface of the skin (see Figure S1 for the picture illustrating flexibility). A thin
aluminum layer was embedded in the middle of one external wall so
that NO release can only be emitted through the outer silicone layer/wall
on one side of the device (i.e., the side that eventually would be
applied to the exterior of the wound) (see Figure for device configuration).
Figure 1
Design of NO-releasing
antimicrobial patch containing (a) PDMS,
(b) aluminum layer in the middle of base wall (18 μm), (c) silver/silver
chloride mesh as a reference/counter electrode, (d) PDMS spacer, (e)
gold sputtered stainless steel mesh as a working electrode, (f) silicone
rubber as a membrane, (g) sealed with silicone adhesive, and (h) connected
with portable voltage supplier.
Design of NO-releasing
antimicrobial patch containing (a) PDMS,
(b) aluminum layer in the middle of base wall (18 μm), (c) silver/silverchloride mesh as a reference/counter electrode, (d) PDMS spacer, (e)
gold sputtered stainless steel mesh as a working electrode, (f) silicone
rubber as a membrane, (g) sealed with silicone adhesive, and (h) connected
with portable voltage supplier.A 3D printer using polylactic acid (PLA) as the polymer cartridge
agent was employed to create a mold and offers considerable design
freedom with resolution of 500 μm dimensions via the use of
the 3D design software Solidworks. Using the printed PLA devices as
the mold, the PDMS patches can be created in various dimensions from
10 to 45 mm in width and 1 to 10 mm in thickness (see experimental
details in the Supporting Information).
In the following experiments, most of the patches are 40 × 40
× 6 mm in size, unless otherwise specified. A gold-coated stainless
mesh and a silver/silver chloride (Ag/AgCl) mesh were incorporated
into the device, serving as the working electrode and the reference/counter
electrode, respectively. A porous PDMS spacer (also created using
a 3D printed mold) was placed in between the two meshes to avoid direct
electric contacts between the electrodes. The inner chamber of the
device was then filled with a solution containing 4 mM CuTPMA, 0.4
M sodium nitrite, 0.2 M NaCl, and 0.5 M HEPES buffer (pH 7.2).The portable voltage supplier is battery operated and consists
of a microcontroller (that incorporates an analog-to-digital converter),
a low-pass filter, and an operational amplifier. The microcontroller
generates a pulse-width modulated digital signal that is passed through
the low-pass filter, converting the digital signal into an analog
signal with a constant voltage. The analog output voltage can be programmed
to any level within the range of ±1 V. The low-pass filter is
followed by an operational amplifier in a unity-gain configuration,
which forms an output stage capable of supplying electrical currents
to support the electrochemical reduction of nitrite. The system operates
in a closed loop, with the output voltage continuously monitored and
adjusted to be at the preprogrammed level.The amount of released
NO in the wound patch system was analyzed
using various applied potentials between the Au mesh electrode and
the Ag/AgCl electrode. As shown in Figure , the amount of NO flux coming from the surface
of the device is in the range of 0.7 to 8.4 × 10–10 mol min–1 cm–2 at applied voltages
in the range of −0.2 to −0.5 V. The NO flux increases
as the potential increases from −0.1 V to −0.4 V. At
even more negative potentials, we observed a decrease in the NO flux,
which can be attributed to the oxidation of NO on the counter electrode.
For most experiments, a voltage of −0.44 V was employed, and
this voltage can be readily applied using a portable battery system
to yield an NO surface flux >80% of the maximum flux with more
tolerance
of voltage drifting. It was also found that >85% of the NO flux
is
released from the top side (no aluminum foil, Figure f) of the device, whereas <5% of the NO
is released from the back side of the patch (aluminum foil incorporated, Figure a) demonstrating
that aluminum layer indeed blocks the NO diffusion effectively as
designed (see Figure S2).
Figure 2
Control of NO release
fluxes (black line) from a PDMS patch with
0.4 M NaNO2, 0.2 M NaCl, 4 mM Cu(II)TPMA, 0.5 M HEPES buffer
under various cathodic voltages (red line) at room temperature.
Control of NO release
fluxes (black line) from a PDMS patch with
0.4 M NaNO2, 0.2 M NaCl, 4 mM Cu(II)TPMA, 0.5 M HEPES buffer
under various cathodic voltages (red line) at room temperature.The lifetime of NO release for
the new patch system was tested
continuously for 4 d. As shown in Figure , the PDMS patch exhibited NO fluxes of 8–10
× 10–10 mol cm2-min–1 during the first 2 days as measured by a chemiluminescence NO analyzer.[21] However, the signal dropped to half of these
values by day 3 and day 4. This drop is not due to the loss of battery
power as the value of NO obtained using a potentiostat showed the
same level of decrease on days 3 and 4. A change in the composition
of the inner filling solution, including a reduction in nitrite levels,
or increase in the pH that slows the NO generation reaction is likely
to occur. Nonetheless, using a syringe with a small needle, it is
viable to replace the inner solution with fresh CuTPMA and nitrite
solution as the device’s PDMS walls would be self-sealing after
removal of the needle. For the purpose of demonstration, we replaced
the inner filling solution on day 4 with a fresh solution using a
syringe (see Movie S1) and restored the
flux (Figure ). In
practice, small Luer Lock ports for removing and refilling the solution
can be designed onto the patch, which will greatly facilitate solution
changing.
Figure 3
Continuous NO release profile from wound healing patches at −0.4
V over 4 days (n = 3 patches, error bars indicate
standard deviation). The internal solution is replaced by a fresh
nitrite/copper complex solution on day 4 using a syringe to restore
the flux as indicated by the arrow.
Continuous NO release profile from wound healing patches at −0.4
V over 4 days (n = 3 patches, error bars indicate
standard deviation). The internal solution is replaced by a fresh
nitrite/copper complex solution on day 4 using a syringe to restore
the flux as indicated by the arrow.To investigate the
effectiveness of the electrochemical NO releasing
patch to kill bacteria via released NO, we selected E. coli and S. aureus as microbial strains for in vitro
studies. Both of these bacteria are common pathogens associated with
skin and soft tissue infections.[22] First,
the efficacy of the NO releasing patch was tested in liquid media
because the cell counting method in the liquid phase can provide an
exact change in the cell number. After 6 h of NO release to a solution
of E. coli or S. aureus (with original
cell counts of 1 × 105 CFU/mL), 35 and 20% of these
two organisms were killed, respectively. After 24 h, 99% of the E. coli was removed and none of S. aureus survived (see Figure ). At 48 h, 99.9% of the E. coli was removed. Note
that the detection limit for cell counting was 20 CFU/mL due to the
serial dilution.
Figure 4
Plate counting of viable E. coli and S.
aureus on the surface of patches with NO turned on for 6,
24, and 48 h (n = 3 for each strain. *p < 0.01; S. aureus: n = 3, **p < 0.05). Patch control is a plain patch without inner
filling solution. Patch/nitrite control is the patch with inner nitrite
solution. Patch NO is the patch where NO release is turned “on”.
Plate counting of viable E. coli and S.
aureus on the surface of patches with NO turned on for 6,
24, and 48 h (n = 3 for each strain. *p < 0.01; S. aureus: n = 3, **p < 0.05). Patch control is a plain patch without inner
filling solution. Patch/nitrite control is the patch with inner nitrite
solution. Patch NO is the patch where NO release is turned “on”.A solid phase antimicrobial test
approach was also examined since
the patch ultimately will be directly employed on the surface of skin.
In this configuration, PDMS patches equipped with the battery power
circuit were applied onto plated blood agar gels that were inoculated
with E. coli and S. aureus cultures.
A PDMS patch without applying voltages to the working Au mesh electrode
was also tested on the same inoculated agar plates as a control. After
2 days of culturing, no E. coli or S. aureus bacteria were found in the regions where the NO releasing patches
were applied, while significant cell growth pertained in the areas
under the control patch regions (see Figure ). This confirms that electrochemically released
NO from the proposed PDMS patches significantly decrease the viability
of the bacteria. We did not observe an inhibition zone, perhaps because
of the relatively low NO flux compared to most studies where an inhibition
zone is observed.[11,12] It should be noted that NO fluxes
in our study cause no toxicity to mammalian cells.[11]
Figure 5
Antimicrobial test of the electrochemical NO releasing patches
on blood agars with E. coli (left) and S.
aureus (right). E. coli and S. aureus were grown for 48 h, and NO was turned on for the PDMS patches for
24 h. The patches have been removed to better show the bacteria under
the patches, with dashed lines indicating the location of the patches
during the experiment.
Antimicrobial test of the electrochemical NO releasing patches
on blood agars with E. coli (left) and S.
aureus (right). E. coli and S. aureus were grown for 48 h, and NO was turned on for the PDMS patches for
24 h. The patches have been removed to better show the bacteria under
the patches, with dashed lines indicating the location of the patches
during the experiment.In addition to the bactericidal effect, NO has also shown
several
other beneficial effects in different processes of wound healing,
including angiogenesis, inflammation, cell proliferation, matrix deposition,
and remodeling. The electrochemical NO releasing patch reported here
would provide a good tool in studying these effects during different
stages of the wound healing, as the temporal profile of NO fluxes
can readily be controlled electrochemically (see Figure ). This is in contrast to most
of the chemical NO release methods, for which the release is passive
and cannot be modulated easily.In summary, we have demonstrated
that a new, low cost, and simple-to-fabricate
electrochemically modulated NO generation patch can be prepared that
releases NO fluxes that are effective in killing/inhibiting Gram-positive
and Gram-negative bacteria that are commonly associated with chronic
wound infections (S. aureus and E. coli). The level of NO release from the surface of the patch that would
contact the skin can be controlled by the magnitude of the applied
voltage between the Au-coated stainless steel mesh working electrode
and the Ag/AgCl reference mesh electrode. For long-term applications,
the inner nitrite/CuTMPA solution will likely need to be changed every
2–3 days to maintain the desired levels of NO flux from the
surface of the device. Of course, in practice, use of modulated release
(e.g., turned “on” periodically for several 2–3
h periods per day) may be all that is needed and this can extend the
lifetime for a given load of inner solution. The next phase of research
will involve testing this patch configuration in animal models of
chronic wounds to prove the effectiveness of the system in enhancing
the wound healing process. Prior studies with NO release patches made
with chemical release of NO have already demonstrated efficacy in
such animal studies.[23]
Authors: Kathryn A Wold; Vinod B Damodaran; Lucas A Suazo; Richard A Bowen; Melissa M Reynolds Journal: ACS Appl Mater Interfaces Date: 2012-06-14 Impact factor: 9.229
Authors: Duane R Hospenthal; Clinton K Murray; Romney C Andersen; Jeffrey P Blice; Jason H Calhoun; Leopoldo C Cancio; Kevin K Chung; Nicholas G Conger; Helen K Crouch; Laurie C D'Avignon; James R Dunne; James R Ficke; Robert G Hale; David K Hayes; Erwin F Hirsch; Joseph R Hsu; Donald H Jenkins; John J Keeling; R Russell Martin; Leon E Moores; Kyle Petersen; Jeffrey R Saffle; Joseph S Solomkin; Sybil A Tasker; Alex B Valadka; Andrew R Wiesen; Glenn W Wortmann; John B Holcomb Journal: J Trauma Date: 2008-03
Authors: Huiping Zhang; Gail M Annich; Judiann Miskulin; Kathryn Osterholzer; Scott I Merz; Robert H Bartlett; Mark E Meyerhoff Journal: Biomaterials Date: 2002-03 Impact factor: 12.479